Peter Mueller - Director, Bioxcel Therapeutics, Inc

As of June 15, 2021


Peter Mueller Net Worth

  • Net worth is estimated to be at least $35.51M
  • Owns at least 168,320 units of Bioxcel Therapeutics, Inc stock

Peter Mueller Trading

  • Largest purchase of shares was 8,446 units , worth over $73.84K on August 23, 2019
  • In total has made about 9 transactions over 3 years
  • Usually trades in December, August and May, with the busiest year in 2019 and 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Bioxcel Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Vimal Mehta, Ph.D. 2020 $890,000 - $8,122,500 $556,250 $7,800 $9,576,550
Vimal Mehta, Ph.D. 2019 $459,000 - $1,269,131 $233,000 $7,800 $1,968,931
William P. Kane, Jr. 2020 $245,455 - $4,185,500 $138,699 - $4,569,654
Reina Benabou, M.D., Ph.D. 2020 $197,443 - $2,462,400 $76,341 - $2,736,184
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1720893/000110465921055605/tm212482-3_def14a.htm

Bioxcel Therapeutics, Inc Insider Trading

  • The most recent transaction was 473,250 units sold on June 29, 2021 by Vimal Mehta worth over $14.59M
  • In the last 3 years, insiders at Bioxcel Therapeutics, Inc sold an estimated value of $131.43M and bought an estimated value of $19.96M
  • The most active traders are Vimal Mehta, CEO and President,  Frank Yocca, Chief Scientific Officer,  and Peter Mueller, Director
  • Insider trading is most common in March, with the busiest year in 2021

BioXcel Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1